JENNIFER HOLLOWAY: Open Payments
NPI 1285601898 · NEWTOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,612 in 111 payments from 25 companies in 2025. Trend: 2023 $3,233 · 2024 $4,056 · 2025 $2,612
Food & beverage: $2,612
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $645 |
| AstraZeneca Pharmaceuticals LP | 13 | $462 |
| Exact Sciences Corporation | 8 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $146 |
| Otsuka America Pharmaceutical, Inc. | 4 | $119 |
| Novo Nordisk Inc | 5 | $114 |
| Lilly USA, LLC | 5 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $107 |
| PFIZER INC. | 5 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $86 |
Products named: BREZTRI, VRAYLAR, REXULTI, TRINTELLIX, The Cologuard Plus Collection Kit, QULIPTA, MOUNJARO, UBRELVY.
Industry payments across CT — which companies pay providers there.
